Our current pipeline is focused on blood diseases. We are devoted to discovering, developing and delivering cures for intractable diseases using gene and cell therapies.

Not only do we have excellent teams for our in-house discovery and pre-clinical programs, we also collaborate with world renowned research institutes to enhance the power of discovery. Utilizing our cumulative experience in stem cells and gene modification technology, we are beginning to tap into neurological and immunologic diseases, as well as cancer treatments.